Erin Wright
Stock Analyst at Morgan Stanley
(4.59)
# 218
Out of 5,090 analysts
242
Total ratings
66.09%
Success rate
15.36%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $120.41 | +45.34% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $814.18 | +12.51% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $73.13 | -20.69% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $717.35 | +12.22% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $156.38 | -1.52% | 25 | Oct 30, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $29.73 | +17.73% | 1 | Oct 17, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $163 → $204 | $150.57 | +35.49% | 3 | Oct 14, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $316 → $359 | $333.49 | +7.65% | 4 | Oct 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $89 | $76.75 | +15.96% | 6 | Oct 14, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $25 → $32 | $35.14 | -8.94% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $139.42 | +0.42% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $20.13 | -15.55% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $290 → $277 | $253.02 | +9.48% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $337.63 | -2.26% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $199.19 | -4.61% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $40.71 | -36.13% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $268.42 | +45.29% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $1.74 | +83.91% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $13 | $21.99 | -40.88% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.27 | +104.17% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $184.18 | -6.61% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $333.49 | +76.02% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $261.48 | +14.73% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $11.15 | +276.68% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $227.13 | +26.80% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $184.04 | +91.26% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.73 | +1,079.62% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $541.06 | -66.55% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $62.12 | -72.63% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $33.29 | +263.47% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $575.24 | +0.83% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $9.57 | +265.92% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $185.45 | +10.54% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $28.29 | -61.12% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $224.92 | -30.20% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $2.55 | +566.67% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $448.35 | -31.30% | 1 | Oct 25, 2017 |
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $120.41
Upside: +45.34%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $814.18
Upside: +12.51%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $73.13
Upside: -20.69%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $717.35
Upside: +12.22%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $156.38
Upside: -1.52%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $29.73
Upside: +17.73%
Molina Healthcare
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $150.57
Upside: +35.49%
Elevance Health
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $316 → $359
Current: $333.49
Upside: +7.65%
CVS Health
Oct 14, 2025
Maintains: Overweight
Price Target: $82 → $89
Current: $76.75
Upside: +15.96%
BrightSpring Health Services
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $35.14
Upside: -8.94%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $139.42
Upside: +0.42%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $20.13
Upside: -15.55%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $290 → $277
Current: $253.02
Upside: +9.48%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $337.63
Upside: -2.26%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $199.19
Upside: -4.61%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $40.71
Upside: -36.13%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $268.42
Upside: +45.29%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $1.74
Upside: +83.91%
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $21.99
Upside: -40.88%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.27
Upside: +104.17%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $184.18
Upside: -6.61%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $333.49
Upside: +76.02%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $261.48
Upside: +14.73%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $11.15
Upside: +276.68%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $227.13
Upside: +26.80%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $184.04
Upside: +91.26%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.73
Upside: +1,079.62%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $541.06
Upside: -66.55%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $62.12
Upside: -72.63%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $33.29
Upside: +263.47%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $575.24
Upside: +0.83%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $9.57
Upside: +265.92%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $185.45
Upside: +10.54%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $28.29
Upside: -61.12%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $224.92
Upside: -30.20%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $2.55
Upside: +566.67%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $448.35
Upside: -31.30%